Case Report: Histopathology of Fatal Respiratory Distress Caused by \u3ci\u3ePlasmodium vivax\u3c/i\u3e Malaria by Valecha, Neena et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Public Health Resources Public Health Resources
2009
Case Report: Histopathology of Fatal Respiratory
Distress Caused by Plasmodium vivax Malaria
Neena Valecha
National Institute of Malaria Research
Rock G.W. Pinto
Department of Pathology, Goa Medical College
Gareth D.H. Turner
Department of Cellular Pathology, Level 1, John Radcliffe Hospital, Oxford
Ashwani Kumar
National Institute of Malaria Research, Field Unit, Directorate of Health Services Building
Savio Rodrigues
Department of Microbiology, Goa Medical College and Hospital
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/publichealthresources
This Article is brought to you for free and open access by the Public Health Resources at DigitalCommons@University of Nebraska - Lincoln. It has
been accepted for inclusion in Public Health Resources by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.
Valecha, Neena; Pinto, Rock G.W.; Turner, Gareth D.H.; Kumar, Ashwani; Rodrigues, Savio; Dubhashi, Nagesh G.; Rodrigues,
Edmond; Banaulikar, Sidhartha S.; Singh, Ruchi; Dash, Aditya P.; and Baird, J. Kevin, "Case Report: Histopathology of Fatal
Respiratory Distress Caused by Plasmodium vivax Malaria" (2009). Public Health Resources. 396.
http://digitalcommons.unl.edu/publichealthresources/396
Authors
Neena Valecha, Rock G.W. Pinto, Gareth D.H. Turner, Ashwani Kumar, Savio Rodrigues, Nagesh G.
Dubhashi, Edmond Rodrigues, Sidhartha S. Banaulikar, Ruchi Singh, Aditya P. Dash, and J. Kevin Baird
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/
publichealthresources/396
Am. J. Trop. Med. Hyg., 81(5), 2009, pp. 758–762
doi:10.4269/ajtmh.2009.09-0348
Copyright © 2009 by The American Society of Tropical Medicine and Hygiene
758
* Address correspondence to Neena Valecha, National Institute of 
Malaria Research, 22-Sham Nath Marg, Delhi 110 054, India, E-mail: 
 neenavalecha@gmail.com; and Kevin Baird, Eijkman-Oxford Clinical 
Research Unit, Jalan Diponegoro No.69, Jakarta 10430, Indonesia, 
E-mail: kbaird@eocru.org.
 Case Report: Histopathology of Fatal Respiratory Distress Caused by  Plasmodium vivax Malaria 
 Neena  Valecha , *  Rock G. W.  Pinto ,  Gareth D. H.  Turner ,  Ashwani  Kumar ,  Savio  Rodrigues ,  Nagesh G.  Dubhashi , 
 Edmond  Rodrigues ,  Sidhartha S.  Banaulikar ,  Ruchi  Singh ,  Aditya P.  Dash , and  J. Kevin  Baird * 
 National Institute of Malaria Research, Delhi, India; Departments of Pathology, Microbiology, Medicine and Forensic Medicine, Goa Medical 
College and Hospital, Bambolim, Goa, India; Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, 
Oxford, United Kingdom; National Institute of Malaria Research Field Unit, Goa, India; Southeast Asian Infectious Diseases Clinical Research 
Network, Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, 
Oxford University, Oxford, United Kingdom 
 Abstract.  An otherwise healthy 20-year-old woman in Goa, India, received antibiotics after a diagnosis of upper respi-
ratory tract infection. One week later, vivax malaria was diagnosed at a health center, but the patient developed respira-
tory distress and lost consciousness. She arrived at emergency department in shock, breathless, and comatose. She died 
within minutes. Two independent laboratories later confirmed  Plasmodium vivax by microscopy (140,000/μL) and by 
nested and real-time polymerase chain reaction methods. Post-mortem examination showed congestion of alveolar cap-
illaries by heavy monocytic infiltrates, along with diffuse damage to alveolar membranes consistent with acute respira-
tory distress syndrome. Parasites seen in lung tissue were roughly proportionate to both peripheral hyperparasitemia and 
those seen in other organs without lesions. In this patient, vivax malaria caused a rapidly fatal respiratory distress. 
 INTRODUCTION 
 Plasmodium vivax causes malaria in 70–390 million people 
annually, with an estimated 2.6 billion living at risk. 1,2 Grassi 
and Feletti3 named  this parasite in 1890, then known as benign 
tertian malaria. The pernicious course of the other tertian 
malaria,  Plasmodium falciparum , prompted the name malig-
nant tertian malaria. Contemporary medical texts describe 
vivax malaria as rarely causing fatal complications. Recent case 
reports, 4–6 case series, 7,8 and hospital-based studies 9–11 challenge 
the notion of vivax malaria as rarely serious, complicated, or 
threatening to life. Among patients with vivax malaria having 
definitively ruled out infection by  P. fal ciparum , there has been 
severe malarial anemia, cerebral malaria, acute respiratory 
distress syndrome (ARDS), renal failure, hepatic dysfunc-
tion, sepsis, and shock. 12,13 Autopsy of a patient with a diagno-
sis of vivax malaria confirmed by molecular biologic methods 
has not been reported. Autopsies are rarely performed in 
South and Southeast Asian countries for a variety of social 
and economic reasons. However, to discourage dowry-moti-
vated homicide, 14 India enacted legislation requiring autopsy 
on death of recently married women. Here we report a post-
mortem examination of a recently married young woman who 
died in respiratory distress caused by vivax malaria. 
 CASE REPORT 
 In June 2008, a woman 20 years of age died in hospital at 
Goa in southwestern India. Family members reported that in 
the week before death, private practitioners had treated the 
patient with ampicloxacillin, diclofenac, and antipyretics for 
an upper respiratory tract infection. At that time she had inter-
mittent fever and chills with body achiness. On the day of death 
she reported to a primary health care center with abdominal 
pain and giddiness a few hours duration. Routine microscopic 
examination of Giemsa-stained thick blood films at the health 
center identified many trophozoites of  P. vivax . Before any 
therapy could be administered, the patient developed respi-
ratory distress and lost consciousness. She was transferred to 
the hospital emergency room. On arrival, she was in shock, 
gasping for breath, febrile (38.3°C), and comatose with no 
sign of neck rigidity. Her blood pressure was not measurable. 
Chest sounds were clear, and heart sounds were normal. She 
was jaundiced, and the abdomen was distended with liver pal-
pable 4 cm below costal margin. The spleen was not palpable. 
The patient was being transferred to the intensive care unit for 
mechanical ventilation when she suffered cardiopulmonary 
arrest. Attempts to resuscitate her were not successful. 
 Subsequent laboratory evaluations of samples taken at 
admission showed normal hemoglobin (15.0 g/dL), blood urea 
(25 mg/dL), blood urea nitrogen (BUN)  (8 mg/dL), and total 
leukocyte count (7,700/μL with 50% neutrophils). Blood sugar 
(65 mg/dL) was slightly below the normal range. Commercially 
available rapid diag nostics for leptospirosis (Leptocheck IgM 
capture), dengue fever (IgM ELISA), enteric fever (blood 
culture and Widal agglutination test), hepatitis (rapid test for 
surface antigen), and HIV 1 and 2 (ELISA) were all nega-
tive. Microscopic examination of Giemsa-stained thick films 
showed parasitemia of trophozoites of  P. vivax numbering 
~140,000/μL blood ( Figure 1 ). A rapid antigen (HRP2) detec-
tion kit for falciparum malaria was negative. Chest roentgeno-
grams were not possible because of the rapidly fatal course. 
 In the months after death, polymerase chain reaction 
(PCR) was performed at two separate laboratories to con-
firm the microscopic diagnosis and rule out co-infection with 
 P .  falciparum . At the National Institute for Malaria Research 
(NIMR) in India, DNA was isolated from fixed and stained 
thick and thin blood smears taken in the emergency depart-
ment immediately before death using the QIAGEN DNA 
isolation kit . PCR analysis was done by nested PCR assay 
along with various  Plasmodium species as control. 15 The US 
Naval Medical Research Unit No. 2 (NAMRU-2) in Jakarta, 
Indonesia, blindly read blood films by microscopy and also 
applied both standard nested and real-time PCR methods 
from DNA extracted from those slides. 16,17 At both laborato-
ries, the microscopic and PCR diagnoses were consistently pos-
itive for  P. vivax and negative for all other species evaluated 
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( P. falciparum, Plasmodium malariae, Plasmodium ovale , and 
 Plasmodium knowlesi ;  Figure 2 ). 
 At autopsy, the congested and edematous lungs weighed 480 
and 460 g, ~35% heavier than normal lungs in Indian women. 
The brain and liver were congested but within normal weight 
ranges at 1,080 and 1,350 g, respectively. The spleen weighed 
250 g (well above normal weight of ~130 g), and it was enlarged 
with a smooth surface without evidence of rupture. Microscopic 
examination of post-mortem tissue samples from major organs 
was done using standard histologic stains including hematoxylin 
and eosin, Martius scarlet blue (MSB), and elastin von Gieson 
(EVG) performed by two independent pathologists (one 
experienced in the diagnosis of fatal falciparum malaria). The 
examinations confirmed an absence of sequestration of para-
sitized erythrocytes in the brain, with none of the characteristic 
pathologic features of cerebral malaria caused by  P. falciparum 
infection. Sections of the spleen showed marked dilation and 
congestion of sinusoids, increased hemozoin pigment, and 
scanty malarial parasites. Sections of the liver showed dilation 
and congestion of sinusoids, mild steatosis, increased hemozoin 
pigment deposition in Küppfer cells, and occasional malaria 
parasites. Sections of the kidney showed congestion and para-
sites in the glomeruli, with significant post-mortem autolysis 
but no clear evidence of acute tubular necrosis or background 
glomerular disease. Examination of the gastrointestinal and 
reproductive tract tissues showed no lesions. 
 Sections from the lung showed focal pulmonary edema 
( Figure 3A ) and variable but focally marked congestion of the 
alveolar capillaries and larger vessels by mononuclear cells, 
predominantly monocytes and lymphocytes, with only scat-
tered neutrophils ( Figure 3A and B). No intra-alveolar consol-
idative pneumonia was seen. There were early signs of diffuse 
alveolar damage with focal hyaline membrane formation posi-
tive on MSB staining ( Figure 3C ). Sections from the lung were 
immunostained, again using standard protocols, for the leuko-
cyte markers CD3 (T cell), CD19 (B cell), and CD68 (mono-
cyte/macrophage). The inflammatory infiltrate, forming an 
early pneumonitis like picture, was predominantly monocytic 
on immunophenotyping, many of which contained phagocy-
tosed pigment. Scanty surviving parasitized erythrocytes were 
also present, and some lymphocytes, with only small numbers 
of neutrophils ( Figure 3D ). No pre-existing granulomatous or 
interstitial lung disease was seen, and background interstitial 
connective tissue appeared normal on EVG staining . 
 There was no evidence of illness other than vivax malaria. 
Initial misdiagnosis as an upper respiratory tract infection 
led to inappropriate therapy and a significant delay in mak-
ing the correct diagnosis. The patient was neither anemic nor 
malnourished. Evidence of active co-infections was not found. 
Although in agonal coma caused by shock, she had no clinical 
evidence of encephalopathy, and histopathologic examination 
of the brain showed no lesions. Antibiotic therapy during the 
week before death, negative blood cultures, and normal leu-
kocyte counts at admission all argued against bacterial sep-
sis. In summary, laboratory studies showed conclusively that 
this patient had vivax malaria without evidence of falciparum 
malaria or any other infection. Post-mortem histopathologic 
analysis of her organs showed pulmonary pathology consistent 
with early ARDS and no other significant findings in other 
organs that could account for death. She was a native of Goa, 
where in 2008, the annual incidence of malaria was 48/1,000 
residents, with about one half of those caused by  P. vivax . 
 DISCUSSION 
 Survey of published reports showed thrombocytopenia 
as the most common serious complication of vivax malaria, 
followed by pulmonary, hepatic, renal, and cerebral compli-
cations. 18 In some endemic settings, severe malarial anemia 
represents the majority of severe complications. 10,11 Several 
dozen cases of ARDS caused by vivax malaria have been 
documented, including cases with PCR confirmation of diag-
nosis. 5,6 We found only three reports of histopathologic exami-
nation of fatal pulmonary complications allegedly caused by 
vivax malaria. Those cases were reported in the early 1900s 
and the diagnoses lacked PCR confirmation of  P. vivax and 
exclusion of  P. falciparum . 19,20 Autopsy of this case, made pos-
sible by legislation aimed at discouraging homicide, permit-
ted histopathologic examination of all organs. Only the lungs 
 Figure 1.  Microscopic diagnosis. Thick blood film taken immediately 
before death showing heavy parasitemia composed of young trophozo-
ites (upward arrows) and the distinctive ameboid trophozoites of  P. vivax 
(downward arrows). This figure appears in color at www.ajtmh.org. 
 Figure 2.  PCR diagnosis. Gel electrophoresis of PCR amplifica-
tion products of the 18s ribosomal RNA gene from DNA extracted 
from blood films taken from the patient immediately before death 
with negative control (far left) and positive controls for each species 
evaluated. Real-time PCR analyses failed to show  P. ovale in patient 
blood (data not shown). 
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showed lesions consistent with the clinical course and outcome 
in this patient, and those were consistent with early ARDS. 
 The post-treatment inflammatory response may exacerbate 
lung injury in vivax malaria, 21 but in this case and others, 4 no 
antimalarial treatment was given. The true pathophysiologic 
significance of lung disease may involve soluble mediators and 
endothelial damage, hypoxia, and systemic shock, leading to 
a common pathway of diffuse alveolar-capillary damage pre-
senting with the clinical syndrome of ARDS. Sequestration of 
mature stages of  P. vivax –infected erythrocytes in the pulmo-
nary microvasculature has been hypothesized based on uncou-
pling of the pretreatment pulmonary capillary vascular and 
the alveolar-capillary membranous components of gas trans-
fer. 21 In this case, the degree of parasite accumulation in the 
lung tissue appeared mild compared with the host leukocyte 
response in the same organ, and similar features have been 
seen histologically in fatal cases of  P. falciparum infection with 
pulmonary complications (G. Turner and others, unpublished 
data). A better measure of the extent of true parasite “seques-
tration” is the sequestration index, 22 comparing the tissue bur-
den of parasites with circulating forms. This allows comparison 
of parasite numbers and stages with the peripheral blood par-
asitemia to determine whether a disproportionate collection 
of parasitized red blood cells has occurred in tissues relative 
to that expected in a free-mixing model. The burden of par-
asitized red blood cells seen in the lung tissues in this case 
appeared low. The scanty parasites observed in tissue sections 
were proportionate to the peripheral hyperparasitemia docu-
mented immediately before death. This raises the possibility 
that end organ damage in fatal malaria caused by  P. vivax may 
be unrelated to parasite load within failing organs. Pulmonary 
phagocytic activity is increased and gas exchange impaired 
during acute uncomplicated vivax malaria. 21,23 Our histopatho-
logic findings in this single fatal case of vivax malaria showed 
heavy intravascular monocytic infiltrates provoking inflam-
matory lesions to the endothelium of the lungs, but without 
marked sequestration of parasitized red blood cells in the pul-
monary microvasculature. 
 Figure 3.  Histologic and immunohistochemical examination of post-mortem lung tissues  A , Low-power micrograph of a lung section show-
ing focal edema and congestion of alveolar capillaries with mononuclear cells, many of which contain phagocytosed pigment (magnification, ×200; 
hematoxylin and eosin).  B , Higher-power view of lung showing occasional parasitized erythrocytes within alveolar capillaries, numerous mononu-
clear cells, and early hyaline membrane formation (magnification, ×400, hematoxylin and eosin).  C , Martius Scarlet Blue staining shows early hya-
line membrane formation in alveolar walls, consistent with ARDS (magnification, ×200).  D , Immunohistochemistry for CD68 showing numerous 
monocyte/macrophages within alveolar capillaries, some of which contain phagocytosed pigment (DAB immunostain with hematoxylin counter-
stain; magnification, ×400). This figure appears in color at www.ajtmh.org. 
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 The number of parasites found in peripheral circulation 
immediately before death represents a very high count rela-
tive to those ordinarily seen in acute vivax malaria. Among 
221 Thai patients with  P. vivax , counts ranged from 45/μL to 
108,000/μL, with a geometric mean of 10,381/μL, for example. 24 
Among 101 Korean patients, parasitemias ranged from 32/μL 
to 52,127/μL (median, 1,287/μL). 25 Among 109 human subjects 
experimentally challenged with the St. Elizabeth strain of 
 P. vivax , parasitemia before therapy was < 10,000/μL in 96% of 
cases, and < 20,000/μL among 99%. 26 Even among 40 severely 
ill patients with  P. vivax in India, 8 including two fatalities, no 
parasitemia exceeded 60,000/μL. Counts substantially exceed-
ing 100,000/μL, although exceptional, are known among natu-
rally infected people. 27 The same was true in at least one series 
of experimental challenge with Chesson strain  P. vivax , where 
parasitemias before therapy among seven subjects reached 
levels ranging from 74,160/μL to 126,000/μL before therapy 
was administered (Collins WE, personal communication). The 
high level of parasitemia occurring in our patient may bear 
on events leading to death (e.g., through provocation of the 
soluble inflammatory mediators that seem responsible for 
lesions observed in the lungs). Hyperparasitemia by  P. vivax 
(perhaps > 100,000/μL) may be a risk factor for severe and 
fatal disease, but the two fatalities in the series of 11 patients 
described from India 7 had parasitemias of only 6,000/μL and 
15,000/μL. Also, in the hospital study from Indonesia by Barcus 
and others, 9 five of nine fatalities caused by  P. vivax had rela-
tively low parasitemia levels. 
 The infection by  P. vivax described here caused ARDS and 
precipitous death within 1 week of onset of illness in an oth-
erwise healthy young woman. Contemporary medical texts 
and training do not ascribe fatal pulmonary complications 
to  P. vivax but to  P. falciparum . With few exceptions (e.g., 
the Korean peninsula),  P. falciparum occurs where there is 
endemic  P. vivax . This case raises the possibility that severe, 
complicated, and life-threatening vivax malaria may be con-
fused for falciparum malaria and highlights the importance of 
applying PCR diagnostics in severely ill patients. 
 Received June 22, 2009. Accepted for publication July 30, 2009. 
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